Impel NeuroPharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.25
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.98
|
0.00
|
0.98
|
100.00%
|
|
2022-12-31
|
-0.94
|
0.00
|
0.94
|
100.00%
|
|
2022-09-30
|
-1.00
|
-1.31
|
-0.31
|
-31.00%
|
|
2022-06-30
|
-1.05
|
-1.09
|
-0.04
|
-3.81%
|
|
2022-03-31
|
-1.05
|
-1.17
|
-0.12
|
-11.43%
|
|
2021-12-31
|
-0.87
|
-1.07
|
-0.20
|
-22.99%
|
|
2021-09-30
|
-0.75
|
-1.24
|
-0.49
|
-65.33%
|
|
2021-06-30
|
-0.60
|
-1.10
|
-0.50
|
-83.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.57
|
|
2021-12-31
|
-18.50
|
|
2020-12-31
|
-0.73
|